![]() ValenTx ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. | AptamiR Therapeutics AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. | ![]() GI Windows GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity. | |
Founding Date | Founding Date 2002 | Founding Date 2012 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Maple Grove, US HQ | Locations Austin, US HQ | Locations Westwood, US HQ |
Employees | Employees 10 | Employees N/A | Employees 244% increase |
Funding | |||
Latest funding round | Latest funding round $ 10.3m (almost 8 years ago) | Latest funding round $ 3m (over 10 years ago) | Latest funding round $ 16.4m (almost 6 years ago) |
Total funding raised | Total funding raised $ 38.1m | Total funding raised $ 3m | Total funding raised $ 42.9m |
AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.
View company
GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity.
View company